Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
25.00
+0.84 (3.48%)
At close: Aug 22, 2025, 4:00 PM
25.00
0.00 (0.00%)
After-hours: Aug 22, 2025, 4:30 PM EDT
Inhibrx Biosciences Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Inhibrx Biosciences.
Price Target: $ (0.00%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Inhibrx Biosciences stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 1 | 1 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 22, 2025 |
JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 15, 2025 |
Citizens Capital Markets | Citizens Capital Markets | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 18, 2025 |
JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 22, 2025 |
JMP Securities | JMP Securities | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Jul 23, 2024 |
Financial Forecast
Revenue This Year
n/a
from 200.00K
Revenue Next Year
4.39M
EPS This Year
-10.95
from 112.62
EPS Next Year
-10.18
from -10.95
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 |
---|---|---|
High | n/a | 4.5M |
Avg | n/a | 4.4M |
Low | n/a | 4.2M |
Revenue Growth
Revenue Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
EPS Forecast
EPS | 2025 | 2026 |
---|---|---|
High | -11.28 | -10.48 |
Avg | -10.95 | -10.18 |
Low | -10.52 | -9.78 |
EPS Growth
EPS Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.